Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...
The first one was that several participants did not know the correct inhaler regimen that they were actively prescribed at ...
Sanofi SA SNY on Tuesday reported Phase 2 data for its experimental therapy lunsekimig in chronic respiratory diseases, ...
The two studies — OBERON and TITANIA — evaluated the drug against placebo in adults with symptomatic COPD who had a history of at least two moderate or at least one severe COPD exacerbations (or ...
Background Severe exacerbation of chronic obstructive pulmonary disease (COPD) is a trajectory-changing life event for patients and a major contributor to health system costs. This study evaluates the ...
Environmental factors including temperature, humidity, air quality, and seasonal changes can significantly impact idiopathic pulmonary fibrosis (IPF). These triggers can exacerbate symptoms and lead ...
In conjunction with World Chronic Obstructive Pulmonary Disease (COPD) Day, organised by the World Health Organisation and the Global Initiative for Chronic Obstructive Lung Disease (GOLD), a research ...
Chronic obstructive pulmonary disease is frequently associated with cardiovascular, metabolic, and psychological diseases, all of which can negatively impact quality of life, exacerbations, and ...
Abstract: Chronic Obstructive Pulmonary Disease (COPD) is the fourth leading cause of death worldwide and is often accompanied by comorbidities. Patients, due to their health condition, may experience ...